Beth Y. Karlan
Cedars-Sinai Medical Center(US)University of California, Los Angeles(US)UCLA Health(US)USC Norris Comprehensive Cancer Center(US)Comprehensive Blood & Cancer Center(US)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, BRCA gene mutations in cancer, Cancer Genomics and Diagnostics, Cancer-related molecular mechanisms research, PARP inhibition in cancer therapy
Most-Cited Works
- → Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer(2015)1,397 cited
- → Ovarian cancer(2016)1,253 cited
- → Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology(2021)1,099 cited
- → Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers(2008)1,067 cited
- → Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk(2015)906 cited
- → Impact of Oophorectomy on Cancer Incidence and Mortality in Women With a BRCA1 or BRCA2 Mutation(2014)644 cited